Superior Vena Cava Syndrome: An Update and Literature Review of Percutaneous Endovascular Treatments

Surbhi B. Trivedi; Charles Ray; Seetharam Chadalavada; Abouelmagd Makramalla; Ali Kord

doi:10.1055/s-0042-1757344

Seminars in Interventional Radiology, Table of Contents

Semin intervent Radiol 2022; 39(04): 446-453
DOI: 10.1055/s-0042-1757344

Trainees Corner

Superior Vena Cava Syndrome: An Update and Literature Review of Percutaneous Endovascular Treatments

Authors

Surbhi B. Trivedi

¹Division of Interventional Radiology, Department of Radiology, the University of Illinois at Chicago, College of Medicine, Chicago, Illinois
Charles Ray

¹Division of Interventional Radiology, Department of Radiology, the University of Illinois at Chicago, College of Medicine, Chicago, Illinois
Seetharam Chadalavada

²Division of Interventional Radiology, Department of Radiology, University of Cincinnati, Cincinnati, Ohio
Abouelmagd Makramalla

²Division of Interventional Radiology, Department of Radiology, University of Cincinnati, Cincinnati, Ohio
Ali Kord

²Division of Interventional Radiology, Department of Radiology, University of Cincinnati, Cincinnati, Ohio

Abstract

Full Text

References

References
1 Hunter W. The history of an aneurysm of the aorta with some remarks on aneurysms in general. Med Obs Enq 1757; 1: 323-357
2 Watkinson AF, Yeow TN, Fraser C. Endovascular stenting to treat obstruction of the superior vena cava. BMJ 2008; 336 (7658): 1434-1437
3 Azizi AH, Shafi I, Shah N. et al. Superior vena cava syndrome. JACC Cardiovasc Interv 2020; 13 (24) 2896-2910
4 Lepper PM, Ott SR, Hoppe H. et al. Superior vena cava syndrome in thoracic malignancies. Respir Care 2011; 56 (05) 653-666
5 Straka C, Ying J, Kong FM, Willey CD, Kaminski J, Kim DWN. Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome. Springerplus 2016; 5: 229
6 Kapur S, Paik E, Rezaei A, Vu DN. Where there is blood, there is a way: unusual collateral vessels in superior and inferior vena cava obstruction. Radiographics 2010; 30 (01) 67-78
7 Hinton J, Cerra-Franco A, Shiue K. et al. Superior vena cava syndrome in a patient with locally advanced lung cancer with good response to definitive chemoradiation: a case report. J Med Case Reports 2018; 12 (01) 301
8 Lanciego C, Pangua C, Chacón JI. et al. Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome. AJR Am J Roentgenol 2009; 193 (02) 549-558
9 Yu JB, Wilson LD, Detterbeck FC. Superior vena cava syndrome – a proposed classification system and algorithm for management. J Thorac Oncol 2008; 3 (08) 811-814
10 Stanford W, Doty DB. The role of venography and surgery in the management of patients with superior vena cava obstruction. Ann Thorac Surg 1986; 41 (02) 158-163
11 Rossi A, Baravelli M, Cattaneo P. et al. Acute superior vena cava syndrome after insertion of implantable cardioverter defibrillator. J Interv Card Electrophysiol 2008; 23 (03) 247-249
12 Singh AK, Pandey A, Upadhyay S. Superior vena cava syndrome due to pulmonary tuberculosis: a rare presentation. J Assoc Physicians India 2020; 68 (09) 73-74
13 Mínguez C, Roca B, González-Miño C, Simón E. Superior vena cava syndrome during the treatment of pulmonary tuberculosis in an HIV-1 infected patient. J Infect 2000; 40 (02) 187-189
14 Mleyhi S, Sandi T, Ben Mrad M. et al. Tuberculosis lymphadenopathy: a rare etiology of the superior vena cava syndrome. J Med Vasc 2021; 46 (01) 9-12
15 Teo N, Sabharwal T, Rowland E, Curry P, Adam A. Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon venoplasty and insertion of metallic stents. Eur Heart J 2002; 23 (18) 1465-1470
16 Lickfett L, Bitzen A, Arepally A. et al. Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace 2004; 6 (01) 25-31
17 Gilard M, Pérennes A, Mansourati J. et al. Stent implantation for the treatment of superior vena cava syndrome related to pacemaker leads. Europace 2002; 4 (02) 155-158
18 Kim YI, Kim KS, Ko YC. et al. Endovascular stenting as a first choice for the palliation of superior vena cava syndrome. J Korean Med Sci 2004; 19 (04) 519-522
19 Friedman T, Quencer KB, Kishore SA, Winokur RS, Madoff DC. Malignant venous obstruction: superior vena cava syndrome and beyond. Semin Intervent Radiol 2017; 34 (04) 398-408
20 Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review. Clin Oncol (R Coll Radiol) 2002; 14 (05) 338-351
21 Ni R, Amr M, Kalla A. Hodgkin lymphoma-associated superior vena cava syndrome: a case report and review of the literature. Am J Case Rep 2021; 22: e929437
22 Ozcan A, Unal E, Karakukcu M, Coskun A, Ozdemir MA, Patiroglu T. Vena cava superior syndrome in the children with mediastinal tumors: single-center experience. North Clin Istanb 2020; 7 (03) 255-259
23 Chan RCL, Chan YC, Cheng SWK. Mid- and long-term follow-up experience in patients with malignant superior vena cava obstruction. Interact Cardiovasc Thorac Surg 2013; 16 (04) 455-458
24 de Gregorio Ariza MA, Gamboa P, Gimeno MJ. et al. Percutaneous treatment of superior vena cava syndrome using metallic stents. Eur Radiol 2003; 13 (04) 853-862
25 Nagata T, Makutani S, Uchida H. et al. Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava. Cardiovasc Intervent Radiol 2007; 30 (05) 959-967
26 Nguyen NP, Borok TL, Welsh J, Vinh-Hung V. Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome. Thorax 2009; 64 (02) 174-178
27 Smayra T, Otal P, Chabbert V. et al. Long-term results of endovascular stent placement in the superior caval venous system. Cardiovasc Intervent Radiol 2001; 24 (06) 388-394
28 Cho Y, Gwon DI, Ko GY. et al. Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective?. Korean J Radiol 2014; 15 (01) 87-94
29 Chen B, Lin R, Dai H. et al. Sharp recanalization for treatment of central venous occlusive disease in hemodialysis patients. J Vasc Surg Venous Lymphat Disord 2022; 10 (02) 306-312
30 Keller EJ, Gupta SA, Bondarev S, Sato KT, Vogelzang RL, Resnick SA. Single-center retrospective review of radiofrequency wire recanalization of refractory central venous occlusions. J Vasc Interv Radiol 2018; 29 (11) 1571-1577
31 Guimaraes M, Schonholz C, Hannegan C, Anderson MB, Shi J, Selby Jr B. Radiofrequency wire for the recanalization of central vein occlusions that have failed conventional endovascular techniques. J Vasc Interv Radiol 2012; 23 (08) 1016-1021
32 Fagedet D, Thony F, Timsit JF. et al. Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy. Cardiovasc Intervent Radiol 2013; 36 (01) 140-149
33 Haddad MM, Simmons B, McPhail IR. et al. Comparison of covered versus uncovered stents for benign superior vena cava (SVC) obstruction. Cardiovasc Intervent Radiol 2018; 41 (05) 712-717
34 Deshwal H, Ghosh S, Magruder K, Bartholomew JR, Montgomery J, Mehta AC. A review of endovascular stenting for superior vena cava syndrome in fibrosing mediastinitis. Vasc Med 2020; 25 (02) 174-183
35 Kishi K, Sonomura T, Mitsuzane K. et al. Self-expandable metallic stent therapy for superior vena cava syndrome: clinical observations. Radiology 1993; 189 (02) 531-535